So, it has not been the best end to the week (to say the least). If we want to try and put the best spin on it, then I would say that the sector has outperformed. If you would have told me that the broader markets were going to be this weak, then I would […]
April 1st Biotech Update
So I think it is safe to say that the sector has broken down. While rates have become a more favorable backdrop, the regulatory uncertainty combined with political risks have overwhelmed everything that could have boosted the sector. I do not think we will be able to get into a bull market until that resolves. […]
Unveiling Volt Lithium: A Groundbreaker in America’s Lithium Revolution
While the world searches for helpful sustainable energy solutions, one small-cap company quietly changing the lithium industry landscape in the United States. Headquartered in Calgary, Canada, Volt Lithium Corp. (TSXV: VLT.v – US, OTC: VLTLF) has become the only operational Direct Lithium Extraction (DLE) operator on the continent, with a working field unit, converting oilfield […]
March 20th Biotech Update
Are we bottoming and setting up a nice long base from which to start a bull market? Perhaps. It seems like investors are getting used to the uncertainty to an extend even if there has not been a lot that has been firmly resolved. There has not been a government shut down. RFK JR. has […]
Mailing List
Introduction
Overview
Founded in 2011, Chimera Research Group provides completely independent and actionable investment and trading ideas backed by comprehensive fundamental research and analysis for listed companies in the biotech and pharmaceutical sectors. Our coverage focuses on early stage companies with impending FDA decisions or clinical trial results but also includes mid-to-large cap bio-pharma companies where there exists specific catalysts. Our Trade Ideas are designed to maximize the risk reward profile. Our Research Reports outline the top up-and-coming catalysts that represent the best opportunities for traders and investors.
The biopharmaceutical sector offers significant opportunities to generate big returns yet can be risky and difficult to navigate.
Subscribe to Chimera Research Group and proceed with confidence.
